Family · Pharmaceutical analytical standards
Risperidone
An atypical, or second-generation, antipsychotic studied from the late 1980s and approved in the United States in 1993 for schizophrenia; later also for bipolar mania and irritability associated with autism. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?In the body it is converted into 9-hydroxyrisperidone, an active metabolite that became an antipsychotic medicine in its own right under the name paliperidone.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
